Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02270931 · ClinicalTrials.gov registry record
A Prospective Longitudinal Breast Cancer Study
A clinical trial of Breast Cancer, sponsored by Fujirebio Diagnostics.
- Completed
- Registry status
- 130
- Enrollment target
- 3
- Study locations
NCT02270931: Completed study of Breast Cancer, sponsored by Fujirebio Diagnostics.
NCT02270931 is a study of Breast Cancer that has completed, run by Fujirebio Diagnostics. The registered enrollment target is 130 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02270931, a study of Breast Cancer, has completed, sponsored by Fujirebio Diagnostics.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to obtain sufficient specimens and correlating clinical data from a well-controlled prospective clinical trial collecting longitudinal specimens from subjects diagnosed with any stage of breast cancer.
Primary Outcome
130 patients with Recurrence or Progressive Breast Cancer.
Conditions Studied
Interventions
- DEVICE CA 15-3 Assay
Study Locations (3)
Florida
- Jane Skelton, MD - Boca Raton
- Broward Health Medical Center - Fort Lauderdale
North Carolina
- New Hanover Regional Medical Center - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2014-05 |
| Est. Completion | 2021-06-30 |
What the finished NCT02270931 record still lists
NCT02270931 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which CA 15-3 Assay is the first listed.
NCT02270931 reports a single indexed study location in Florida, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02270931 about?
NCT02270931 is a clinical study titled "A Prospective Longitudinal Breast Cancer Study". The purpose of this study is to obtain sufficient specimens and correlating clinical data from a well-controlled prospective clinical trial collecting longitudinal specimens from subjects diagnosed with any stage of breast cancer.
What is the current status of trial NCT02270931?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2014-05. Estimated completion is 2021-06-30.
What conditions does trial NCT02270931 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT02270931?
The interventions under investigation include: CA 15-3 Assay (DEVICE).
Who is sponsoring clinical trial NCT02270931?
This trial is sponsored by Fujirebio Diagnostics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02270931 being conducted?
This trial has 3 study locations across Florida, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02270931's enrollment target sits among peer trials
130 489th of 1224 higher than 730 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia